CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment

Mary E. Law, Renan B. Ferreira, Bradley J. Davis, Paul J. Higgins, Jae Sung Kim, Ronald K. Castellano, Sixue Chen, Hendrik Luesch, Brian K. Law

Research output: Contribution to journalArticlepeer-review

20 Scopus citations


Background: While localized malignancies often respond to available therapies, most disseminated cancers are refractory. Novel approaches, therefore, are needed for the treatment of metastatic disease. CUB domain-containing protein1 (CDCP1) plays an important role in metastasis and drug resistance; the mechanism however, is poorly understood. Methods: Breast cancer cell lines were engineered to stably express EGFR, CDCP1 or phosphorylation site mutants of CDCP1. These cell lines were used for immunoblot analysis or affinity purification followed by immunoblot analysis to assess protein phosphorylation and/or protein complex formation with CDCP1. Kinase activity was evaluated using phosphorylation site-specific antibodies and immunoblot analysis in in vitro kinase assays. Protein band excision and mass spectrometry was utilized to further identify proteins complexed with CDCP1 or CDCP1, which is a mimetic of the cleaved form of CDCP1. Cell detachment was assessed using cell counting. Results: This paper reports that CDCP1 forms ternary protein complexes with Src and EGFR, facilitating Src activation and Src-dependent EGFR transactivation. Importantly, we have discovered that a class of compounds termed Disulfide bond Disrupting Agents (DDAs) blocks CDCP1/EGFR/Src ternary complex formation and downstream signaling. CDCP1 and EGFR cooperate to induce detachment of breast cancer cells from the substratum and to disrupt adherens junctions. Analysis of CDCP1-containing complexes using proteomics techniques reveals that CDCP1 associates with several proteins involved in cell adhesion, including adherens junction and desmosomal cadherins, and cytoskeletal elements. Conclusions: Together, these results suggest that CDCP1 may facilitate loss of adhesion by promoting activation of EGFR and Src at sites of cell-cell and cell-substratum contact.

Original languageEnglish
Article number80
JournalBreast Cancer Research
Issue number1
StatePublished - Aug 5 2016


  • Adhesion
  • Breast cancer
  • CDCP1
  • E-cadherin
  • EGFR
  • Src


Dive into the research topics of 'CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment'. Together they form a unique fingerprint.

Cite this